Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing two types of spacers for treating knee joint infections

Official title: Durable, Real-component Antibiotic Spacers vs All-cement Articulating Spacers for the Treatment of Periprosthetic Knee Infection

Run by Northwestern University · NCT06293352 · Data updated 2026-11-12

This study is testing which type of spacer works better for treating knee joint infections in patients who have had knee replacement surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment153 (estimated)
SponsorNorthwestern University
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedAugust 8, 2024
Main results expectedAugust 2027
Study endsAugust 2028
Registry record updatedAugust 24, 2026
Trial IDNCT06293352 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients diagnosed with chronic periprosthetic joint infections after a primary total knee arthroplasty who are scheduled for explant and placement of an antibiotic spacer.

Probably not a fit

Patients with infections at the site of revision, significant soft tissue compromise, or those unable to consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares two treatment methods for chronic periprosthetic joint infections following total knee arthroplasty. One method uses an all-cement articulating spacer, while the other employs a durable, real-component articulating spacer. Patients will be randomly assigned to one of the two cohorts, and their outcomes will be assessed through preoperative patient-reported outcomes questionnaires administered via iPad or online. The goal is to determine which spacer type leads to better infection management and patient outcomes.

Why it matters

Potential benefit: If successful, this study could improve treatment options for patients with knee joint infections, potentially leading to better recovery and fewer complications.

How similar studies have gone: While the approach of using different types of spacers is established, this specific comparison has not been extensively tested, making it a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients diagnosed with a chronic periprosthetic joint infection after a primary total knee arthroplasty with plan for explant and placement of an antibiotic spacer
* PJI defined according to Musculoskeletal Infection Society (MSIS) 2018 Consensus Criteria

Exclusion Criteria:

* Patients who are unable to consent
* Infection at site of revision TKA
* Soft tissue envelope compromise
* Allergies to study materials (cement, vancomycin, tobramycin)
* Incompetent extensor mechanism
* Extensive bone loss

Randomization-specific exclusion criteria

* Extensive soft tissue defect
* Extensor mechanism compromise

Where it's running

  • Northwestern Medicine
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.